MarketPeel
Insider Trading Intelligence
MC

Michael T. Constantino

HUMA
DIRECTOR · HUMACYTE, INC. · CIK 0001817285
FILING MIX · LIFETIME100%/0%
BUYS
14
SELLS
0
TOTAL VALUE
$126.2K
COMPANIES
1
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
80,000
AVG SELL PX
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael T. Constantino, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+42.86%+1.41%+1.30%+0.11%-3.58%
14d7+28.57%-4.57%-0.01%-4.56%-0.79%
30d7+14.29%-13.96%+1.62%-15.58%-21.26%
60d7+14.29%-8.69%+2.77%-11.46%-27.44%
90d7+14.29%-11.38%+3.27%-14.65%-21.34%
180d7+14.29%-28.79%+2.46%-31.25%-39.45%
1y7+14.29%-42.17%+9.91%-52.08%-55.98%
2y7(3 pending)+25.00%-34.88%+21.01%-55.89%-76.29%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HUMA · 80,000 shares · as of Jun 11, 2026
020,00040,00060,00080,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 0 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
80,00080,000Jun 11, 2026Jun 12, 2026View →
HUMA
HUMACYTE, INC.
PURCHASE
11,000$0.89$9.8K43,950May 18, 2026May 20, 2026View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
80,00080,000Jun 12, 2025Jun 16, 2025View →
HUMA
HUMACYTE, INC.
PURCHASE
16,000$1.26$20.2K32,950Apr 7, 2025Apr 8, 2025View →
HUMA
HUMACYTE, INC.
PURCHASE
4,600$4.39$20.2K16,950Dec 4, 2024Dec 4, 2024View →
HUMA
HUMACYTE, INC.
PURCHASE
3,100$6.29$19.5K12,350Aug 15, 2024Aug 15, 2024View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 13, 2024Jun 17, 2024View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,5008,500Jun 15, 2023Jun 16, 2023View →
HUMA
HUMACYTE, INC.
PURCHASE
4,750$4.18$19.9K9,250May 18, 2023May 19, 2023View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
8,5008,500Jun 9, 2022Jun 13, 2022View →
HUMA
HUMACYTE, INC.
PURCHASE
2,000$4.83$9.7K4,500May 23, 2022May 24, 2022View →
HUMA
HUMACYTE, INC.
PURCHASE
200$10.83$2.2K200Nov 22, 2021Nov 24, 2021View →
HUMA
HUMACYTE, INC.
PURCHASE
2,300$10.79$24.8K2,500Nov 22, 2021Nov 24, 2021View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
13,00013,000Oct 13, 2021Oct 15, 2021View →
Other insiders · HUMA
Loading peer insiders…
About this filer
CIK 0001817285
ROLE
Director
PRIMARY
HUMA
COMPANIES
1
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001817285DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback